|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1730 M St NW Ste 611 |
Address2 | |
City | Washington |
State | DC |
Zip Code | 20036 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 501-12
|
||||||||
|
6. House ID# 321540000
|
TYPE OF REPORT | 8. Year | 2009 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: William D. McColl, Political Director |
Date | 01/20/2010 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 1616 - Early Treatment for HIV Act, all sections. Provide States the option to expand Medicaid coverage to early inter-
vention, treatment, and healthcare for people living with HIV.
H. R. 179, Community AIDS and Hepatitis Prevention Act, all sections. Will permit the use of Federal funds for syringe exchange programs for purposes of reducing the transmission of bloodborne pathogens, including HIV and viral hepatitis.
S.611/H.R.1551: The Responsible Education About Life (REAL) Act, all Sections. Support state grants (and evaluation of grants) for family life education programs, including education on abstinence and contraception for the prevention of teenage pregnancy and sexually transmitted infections (STIs), including HIV/AIDS.
H.R.1429: The Stop AIDS in Prison Act, all Sections. Support development of a comprehensive policy to provide HIV testing, treatment, and prevention for inmates within the correctional setting and upon reentry. (Note: passed House Mar. 17th and now received for action in Senate Judiciary Committee).
S.1793/H.R.3792: Ryan White HIV/AIDS Treatment Extension Act of 2009, all Titles. Support four year reauthorization of payer of last resort funding for cities, states, direct clinical services, direct family services, dental, Minority AIDS Initiative (MAI) to provide funding for people living with HIV plus education and training for professionals providing services. Signed into law Oct. 30.
H.R.2996: Interior and Environmet FY 2010 spending bill. Includes continuing appropriations resolution until Dec. 18th. Signed into law Oct. 30, 2009.
H.R.3288: Appropriations for the Departments of Transportation, and Housing and Urban Development, and related agencies for FY 2010. The conference report on the bill includes provisions for six of the seven FY2010 appropriations: Transportation-HUD; Commerce-Justice-Science; Financial Services; Labor-HHS; Military Construction-VA; and State-Foreign Operations. Specifically, the "minibus" bill includes: H.R.3293 (no bill number in Senate) - Labor, Health and Human Services, Education and Related Agencies, Title II. Support increased funding for NIH, HRSA, SAMHSA and CDC including HIV prevention, treatment, education, training and care, and research. Seek removal of ban on spending federal funds for syringe access. End funding for abstinence-only program. H.R.3288 (no bill number in Senate) - Transportation, Housing and Urban Development, and Related Agencies, Title II. Support increased funding for Housing Opportunities for People with AIDS (HOPWA). S.1432/H.R.3170 - Financial Services Appropriations. Support $1.4 million to the White House Office of National AIDS Policy for the development of a National AIDS Strategy. Seek and/or maintain removal of ban on spending federal and local funds for syringe access for Washington D.C. Signed into law Dec. 16, 2009.
H.R. 3590: "Patient Protection and Affordable Care Act" (Senate version of health care reform bill)/H.R.3962 "Affordable Health Care for America Act." (House version of health care reform bill). Support inclusion of Early Treatment for HIV Act, allowing States to cover True Out of Pocket (TrOOP) costs under Medicare Part D with AIDS Drug Assistance Program funds, ending health care disparities, public option, Medicaid expansion, data collection provisions, along with prevention, wellness and public health provisions in health care plans.
H.R. 3001: "Ending LGBT Health Disparities Act," all Titles. Specific support for optional Medicaid coverage of low-income HIV-infected individuals and allowing costs incurred by AIDS drug assistance programs in providing prescription drugs count toward the annual out-of-pocket threshold under Medicare part D.
H.R. 1964: "National Black Clergy for the Elimination of HIV/AIDS Act of 2009," all Titles.
H.R. 2137: "Routine HIV Screening Coverage Act of 2009," all Sections.
H.R. 4140: "Increasing Access to Voluntary Screening for HIV/AIDS and STIs Act of 2009," all Titles.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Disease Control & Prevention (CDC), Health & Human Services - Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Natl AIDS Policy, Office of Natl Drug Control Policy (NDCP), Natl Institutes of Health (NIH)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
William |
McColl |
II |
|
|
Donna |
Crews |
|
|
|
Ronald |
Johnson |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |